Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Regulatory News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

Share Price is delayed by 15 minutes
Get Live Data
12.75    0.50 (4.08%)
Bid:
12.50
Ask:
13.00
Spread: 0.50 (4.00%)
Market Cap: £32.01m
ABDX Live PriceLast checked at - London Stock Exchange

Intraday Abingdon Healt. Share Chart

TR-1

19 Aug 2024 13:48

RNS Number : 9687A
Abingdon Health PLC
19 August 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BLF79J41

Issuer Name

ABINGDON HEALTH PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An event changing the breakdown of voting rights; Other

Comments

This is in relation to the placing of new shares in issue settling 14.08.2024

3. Details of person subject to the notification obligation

Name

Octopus Investments Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

England

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

14-Aug-2024

6. Date on which Issuer notified

15-Aug-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

10.340000

0.000000

10.340000

19606013

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BLF79J41

0

19606013

0.000000

10.340000

Sub Total 8.A

19606013

10.340000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Octopus Capital Limited

Octopus Investments Limited

10.340000

0.000000

10.340000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

15/08/2024

13. Place Of Completion

33 Holborn, London, EC1N 2HT

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFSFTEIALIS
Date   Source Headline
29th Mar 20227:11 amRNSInterim Results
29th Mar 20227:00 amRNSStrategic collaboration with Vatic Health Limited
29th Mar 20227:00 amRNSStrategic collaboration with DeepVerge plc
29th Mar 20227:00 amRNSMoU with Abingdon Health for lateral flow tests
25th Mar 20227:00 amRNSNotice of Results
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:01 amRNSTrading and Strategic Update
2nd Mar 20227:00 amRNSUK Government study gives insight on SARS-CoV-2
28th Feb 20224:41 pmRNSSecond Price Monitoring Extn
28th Feb 20224:36 pmRNSPrice Monitoring Extension
18th Jan 20222:05 pmRNSSecond Price Monitoring Extn
18th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20229:05 amRNSSecond Price Monitoring Extn
10th Jan 20229:00 amRNSPrice Monitoring Extension
10th Jan 20227:05 amRNSUpdate on AffiDX® SARS-CoV-2 antigen LFT
24th Dec 202110:05 amRNSResult of AGM
22nd Dec 202111:06 amRNSSecond Price Monitoring Extn
22nd Dec 202111:01 amRNSPrice Monitoring Extension
21st Dec 20218:40 amRNSDirector/PDMR Shareholding
20th Dec 202111:01 amRNSResults of General Meeting and Open Offer
16th Dec 20217:00 amRNSCE-marking and commercial launch of Semi-Q Test
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension
3rd Dec 202111:07 amRNSPublication of Annual Report and Notice of AGM
2nd Dec 20215:43 pmRNSOpen Offer Launch, Posting of Circular, GM Notice
1st Dec 20211:47 pmRNSResult of Placing, PrimaryBid and Subscription
1st Dec 202111:06 amRNSSecond Price Monitoring Extn
1st Dec 202111:01 amRNSPrice Monitoring Extension
1st Dec 202110:18 amRNSClose of Accelerated Bookbuild & PrimaryBid Offer
1st Dec 20219:05 amRNSSecond Price Monitoring Extn
1st Dec 20219:00 amRNSPrice Monitoring Extension
1st Dec 20217:01 amRNSPrimaryBid Offer
1st Dec 20217:00 amRNSProposed Fundraising
18th Nov 20214:41 pmRNSSecond Price Monitoring Extn
18th Nov 20214:35 pmRNSPrice Monitoring Extension
18th Nov 20212:05 pmRNSSecond Price Monitoring Extn
18th Nov 20212:00 pmRNSPrice Monitoring Extension
18th Nov 202111:06 amRNSSecond Price Monitoring Extn
18th Nov 202111:00 amRNSPrice Monitoring Extension
18th Nov 20217:00 amRNSPreliminary Results
17th Nov 20214:41 pmRNSSecond Price Monitoring Extn
17th Nov 20214:35 pmRNSPrice Monitoring Extension
15th Nov 20217:00 amRNSNotice of Results
4th Oct 202111:06 amRNSSecond Price Monitoring Extn
4th Oct 202111:00 amRNSPrice Monitoring Extension
7th Sep 20217:00 amRNSLaunch of Semi-Quantitative Accessory to AbC-19™
2nd Sep 20214:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:36 pmRNSPrice Monitoring Extension
24th Aug 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.